Back to BNR Stock Lookup
Pages: 1 2 3 »» Last Page

(BNR) –

Jul 14, 2021 04:59 AM CICC Starts Burning Rock Biotech Ltd. (BNR) at Outperform
Jun 23, 2021 03:00 AM Brenntag to acquire JM Swank and thus creates the leading Food Ingredients Distributor in the North American market
May 25, 2021 07:13 AM Form 6-K Burning Rock Biotech For: May 25
May 25, 2021 12:19 AM Burning Rock Reports First Quarter 2021 Financial Results
May 25, 2021 12:19 AM Burning Rock Reports First Quarter 2021 Financial Results
May 19, 2021 05:06 AM Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
May 19, 2021 05:06 AM Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
May 12, 2021 04:00 AM Burning Rock to be Added to MSCI China Index
May 12, 2021 04:00 AM Burning Rock to be Added to MSCI China Index
May 11, 2021 01:00 AM Brenntag achieves very strong results in first quarter 2021 by prudently navigating through fast changing market conditions
Apr 29, 2021 07:30 AM Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091
Apr 29, 2021 07:30 AM Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091
Apr 28, 2021 10:00 PM Burning Rock Schedules First Quarter of 2021 Earnings Release on May 25, 2021
Apr 28, 2021 10:00 PM Burning Rock Schedules First Quarter of 2021 Earnings Release on May 25, 2021
Apr 13, 2021 03:39 AM Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology
Apr 13, 2021 03:39 AM Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology
Mar 23, 2021 09:03 AM Form 20-F Burning Rock Biotech For: Dec 31
Mar 11, 2021 10:20 AM Form 6-K Burning Rock Biotech For: Mar 11
Mar 10, 2021 07:00 PM Burning Rock Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 10, 2021 07:00 PM Burning Rock Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 5, 2021 10:56 AM Form F-6 POS Brenntag AG/ADR Filed by: Deutsche Bank Trust Co Americas/ ADR Group
Feb 19, 2021 05:27 PM Form F-6 POS Brenntag AG/ADR Filed by: Citibank,N.A./ADR
Feb 17, 2021 11:02 AM Form F-6 POS Brenntag AG/ADR Filed by: BANK OF NEW YORK / ADR DIVISION
Feb 12, 2021 05:27 PM Form SC 13G Burning Rock Biotech Filed by: SCC Venture VI Holdco, LTD.
Feb 12, 2021 06:26 AM Form SC 13G Burning Rock Biotech Filed by: Northern Light Venture Fund III, L.P.
Feb 11, 2021 06:18 AM Form SC 13G Burning Rock Biotech Filed by: CMB International Capital Corp Ltd
Feb 11, 2021 06:13 AM Form SC 13G Burning Rock Biotech Filed by: LYFE CAPITAL MANAGEMENT LTD
Feb 9, 2021 06:21 AM Form SC 13G Burning Rock Biotech Filed by: Right Lane Ltd
Feb 9, 2021 06:20 AM Form SC 13G Burning Rock Biotech Filed by: Han Yusheng
Feb 8, 2021 08:00 PM Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021
Feb 8, 2021 08:00 PM Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021
Dec 15, 2020 08:07 AM OncoCyte (OCX) and Burning Rock (BNR) Confirm Strategic Agreement to Distribute DetermaRx in China
Dec 15, 2020 08:00 AM Oncocyte and Burning Rock Execute Strategic Agreement to Distribute DetermaRx in China
Dec 15, 2020 06:54 AM Burning Rock Biotech (BNR) Announces Exclusive in-Licensing of Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte (OCX) in China
Dec 15, 2020 01:33 AM Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
Dec 15, 2020 01:33 AM Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
Dec 8, 2020 06:45 AM Form S-8 Burning Rock Biotech
Dec 4, 2020 10:49 AM Form 424B4 Burning Rock Biotech
Dec 4, 2020 06:36 AM Burning Rock Biotech Limited (BNR) Prices Upsized Registered Secondary Public Offering of ADSs at $25.75/Each
Dec 4, 2020 06:34 AM Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
Dec 4, 2020 06:34 AM Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
Dec 4, 2020 06:05 AM Form EFFECT Burning Rock Biotech
Dec 3, 2020 09:46 PM Form F-1MEF Burning Rock Biotech
Dec 2, 2020 11:03 AM Form F-1/A Burning Rock Biotech
Dec 2, 2020 06:08 AM Form 6-K Burning Rock Biotech For: Dec 02
Dec 2, 2020 06:00 AM Burning Rock Biotech Limited (BNR) Announces Proposed 1.838M ADS Secondary Offering
Dec 1, 2020 06:47 PM Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
Dec 1, 2020 06:46 PM Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
Dec 1, 2020 04:41 PM Form F-1 Burning Rock Biotech
Nov 20, 2020 06:45 AM Form 6-K Burning Rock Biotech For: Nov 20
Pages: 1 2 3 »» Last Page

Back to BNR Stock Lookup